Two Sigma Advisers’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Buy |
|
|||||
|
2025
Q1 | $1.59M | Buy |
|
|||||
|
2024
Q4 | $1.65M | Sell |
|
|||||
|
2024
Q3 | $1.95M | Sell |
|
|||||
|
2024
Q2 | $2.03M | Buy |
|
|||||
|
2024
Q1 | $2.33M | Buy |
|
|||||
|
2023
Q4 | $973K | Buy |
|
|||||
|
2023
Q3 | $618K | Buy |
|
|||||
|
2023
Q2 | $174K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $155K | Sell |
|
|||||
|
2022
Q1 | $703K | Buy |
|
|||||
|
2021
Q4 | $502K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $299K | Buy |
|